Table of Content - Blood Based Biomarker Market

The term biomarker, or biological marker, refers to a broad range of measures that capture what is happening in a cell or organism at a given moment. Blood-based biomarkers can be effective in formulating new diagnostic and treatment proposals. Blood-based biomarkers have significant advantages of being time and cost-efficient

Market Dynamics

Key players operating in the global blood based biomarker market are focusing on adoption of growth strategies such as product launch, collaboration, and fund raise which are expected to drive the market growth during the forecast period. For instance, in September 2020, ONCOtracker, Inc., a West Hollywood-based oncology company and The Binding Site Group Ltd, provides specialist diagnostic products to clinicians and laboratory professionals worldwide, announced they have entered into an exclusive global license and collaboration agreement to develop a novel clinical laboratory test for measuring sBCMA, a novel blood-based biomarker, which has shown promise to monitor and predict outcomes for patients with common blood-based cancers including multiple myeloma (MM) and chronic lymphocytic leukemia (CLL) and other related conditions. Moreover, for instance, in April 2021, Sera Prognostics, a Women’s health company had secured US$100 m in Series E financing to advance the commercialization of its PreTRM test for premature birth risk. The PreTRM test is a clinically validated and commercially available blood-based biomarker test, which offers an early, precise, and individualized risk prediction for spontaneous preterm birth in asymptomatic singleton pregnancies.

Key features of the study:

This report provides an in-depth analysis of the Global Blood Based Biomarker Market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global blood based biomarker market based on the following parameters – Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
Key companies covered as a part of this study include Diadem srl., Proteomedix, Cleveland Diagnostics, F. Hoffmann-La Roche Ltd, GENFIT, Nutech Cancer Biomarkers India Pvt Ltd, SysmOex Corporation, Minomic, Creative Diagnostics, Eisai Co., Ltd., and C2N Diagnostics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global blood based biomarker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood based biomarker market

Detailed Segmentation:

Global Blood Based Biomarker Market, By Type :
- Screening Biomarker
- Diagnosis Biomarker
- Others
Global Blood Based Biomarker Market, By Disease :
- Cancer
- Neurological Disorders
- Others
Global Blood Based Biomarker Market, By Application :
- Diagnostics
- Drug Discovery
- Personalized Medicine
Global Blood Based Biomarker Market, By Region:
- North America
  - By Country
    - U.S.
    - Canada
- Latin America
  - By Country
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - By Country
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - By Country
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - By Country
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - By Country
    - South Africa
    - Central Africa
    - North Africa
Company Profiles
- Diadem srl.*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Proteomedix
- Cleveland Diagnostics
- F. Hoffmann-La Roche Ltd
- GENFIT
- Nutech Cancer Biomarkers India Pvt Ltd
- SysmOex Corporation
- Minomic
- Creative Diagnostics
- Eisai Co., Ltd.
- C2N Diagnostics

“*” marked represents similar segmentation in other categories in the respective section.

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Type
  - Market Snapshot, By Disease
  - Market Snapshot, By Application
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunity
- Impact Analysis
- Regulatory Scenario
- Market Trends
- Key Developments
- Epidemiology
- PEST Analysis
- Collaboration and Acquisition
Global Blood based Biomarkers Market– Impact of Coronavirus (COVID-19) Pandemic
- Economic Impact
- Impact on Demand and Supply
Global Blood based Biomarkers Market, By Type, 2017 – 2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018 – 2030
  - Segment Trends
- Screening Biomarker
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030,(US$ Bn)
- Diagnosis Biomarker
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030,(US$ Bn)
- Others (Prognostic blood-based biomarkers, Safety Biomarker)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030,(US$ Bn)
Global Blood based Biomarkers Market, By Disease, 2017 - 2030,(US$ Bn)
- Introduction
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018 – 2030
  - Segment Trends
- Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030,(US$ Bn)
- Neurological Disorders
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030,(US$ Bn)
- Others (Cardiovascular disease, Metabolic disorders)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030,(US$ Bn)
Global Blood based Biomarkers Market, By Application, 2017 - 2030,(US$ Bn)
- Introduction
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018 – 2030
  - Segment Trends
- Diagnostics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030,(US$ Bn)
- Drug Discovery
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030,(US$ Bn)
- Personalized Medicine
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030,(US$ Bn)
Global Blood based Biomarkers Market, By Region, 2017 - 2030,(US$ Bn)
- Introduction
  - Market Share Analysis, By Region, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, For Regions, 2018-2030
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease, 2017 - 2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2030,(US$ Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease, 2017 - 2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2030,(US$ Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease, 2017 - 2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2030,(US$ Bn)
    - U.K.
    - Germany
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease, 2017 - 2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2030,(US$ Bn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease, 2017 - 2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2030,(US$ Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease, 2017 - 2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2030,(US$ Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profiles
  - Diadem srl.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Proteomedix
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Cleveland Diagnostics
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Hoffmann-La Roche Ltd
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - GENFIT
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Nutech Cancer Biomarkers India Pvt Ltd
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Sysmex Corporation
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Minomic
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Creative Diagnostics
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Eisai Co., Ltd.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - C2N Diagnostics
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
- Analyst Views
Section
- Research Methodology
- About us

*Browse 29 market data tables and 33 figures on "Global Blood based Biomarkers Market” - forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount